教授

岳锐

发布时间:2019-05-08  

姓        名:岳锐

行政职务:生命科学与技术学院副院长

            分子与细胞生物学系主任

学       位:理学博士

导师情况:博士生导师、硕士生导师

研究领域:组织干细胞与再生医学

研究方向:

1.髓内骨骼干细胞与骨-血对话调控;

2.髓外骨骼干细胞与骨-肌对话调控;

3.骨骼/造血干细胞衰老机制与年轻化策略;

E-mail:ryue@tongji.edu.cn

办公室电话:021-65983623

实验室电话:021-65983287

通讯地址:上海市四平路1239号道交馆432室

个人简介:

2005年毕业于浙江大学竺可桢学院工科混合班,获工学学士学位。2011年毕业于中国科学院上海生命科学研究院生物化学与细胞生物学研究所裴钢院士实验室,获理学博士学位。博士阶段主要以斑马鱼和小鼠胚胎干细胞为模型研究G蛋白偶联受体信号通路及其负调控蛋Beta-arrestin1在血液发育中的调控作用。期间荣获吴瑞奖学金、中国科学院院长特别奖、中国科学院优秀博士论文奖、中国科学院研究生院-必和必拓奖学金,以及明治乳业生命科学奖。

2011年至2016年在美国得克萨斯大学西南医学中心Sean Morrison教授(美国科学院院士、美国医学科学院院士、HHMI研究员、2016国际干细胞研究协会主席)实验室从事博士后研究,主要利用小鼠遗传学研究骨髓造血干细胞与骨髓间充质干细胞的调控机制与临床应用。期间荣获Damon Runyon Fellowship以及美国西南医学中心Dean's Discretionary Award

2016年任同济大学生命科学与技术学院教授、上海市信号转导与疾病研究重点实验室研究员、同济大学附属东方医院再生医学研究所研究员。2017年入选国家海外高层次青年人才。2019年任分子与细胞生物学系主任、教育部“细胞干性与命运编辑”前沿科学中心副主任。2020年任生命科学与技术学院副院长(分管科研工作)。2022年荣获CSSCR干细胞卓越青年研究员奖,2023年荣获上海市优秀青年学术带头人,2024年荣获国家杰出青年科学基金。培养研究生荣获吴瑞奖学金、“博新计划”(A类)以及国家奖学金等多项殊荣。 

研究概述:

组织干细胞在器官发育和稳态维持中发挥重要作用,其功能减退是机体衰老的关键诱因之一。本课题组聚焦骨骼与血液系统干细胞调控和衰老相关疾病研究取得了多项成果:1)利用髓内骨骼干细胞(SSC)体外重塑骨髓微环境逆转造血干细胞衰老,解析SSC调控骨血对话和骨髓衰老新机制;2)鉴定多种新型髓外SSC并阐明其在骨骼发育和衰老中的关键作用;3)发现成纤维细胞激活蛋白(Fap)是多种衰老相关重大疾病的潜在治疗靶点。以通讯作者(含共同)在Cell Stem Cell、Cell Res、Circ Res、PNAS和EMBO J等高水平期刊发表研究论文十余篇(5篇入选封面文章),其中2篇获同期配图评述,1篇获年度最佳论文,1篇被Nat Rev Endocrinol和F1000推荐,获批发明专利4项。本课题组未来拟进一步探索髓内和髓外SSC在血液与骨骼系统衰老中的关键作用与调控机制,并基于此研发创新干预策略延缓机体衰老。

在研国家级项目:

1.国家自然科学基金委员会国家杰出青年科学基金, 32425027, 组织干细胞与衰老研究, 2025-01-01  2029-12-31, 400万元在研主持

2.国家自然科学基金委员会重点项目, 32330050, 交感神经信号对骨髓间充质干细胞免疫调节功能的 增强作用与机制研究, 2024-01-01  2028-12-31, 218万元在研主持

3.国家自然科学基金委员会国际(地区)合作与交流项目, 82361148131, 细胞衰老机制及其干预研究, 2023-08-01  2028-07-31, 400万元在研参与

4.科技部,国家重点研发计划(干细胞研究与器官修复),2022YFA1103200,骨骼与血液干细胞休眠和激活调控,2022-122027-122800万元,在研,主持

5.科技部,国家重点研发计划(干细胞研究与器官修复),2021YFA1100900,骨髓内造血干细胞发育和再生的调控机制及干预策略,2021-12至2026-06,182万,在研,参与

6.国家自然科学基金委,面上项目,82070108,IGF-1在骨髓微环境中的调控作用研究,2021-01至 2024-12,56万元,在研,主持

已结题国家级项目:

1.科技部,国家重点研发计划(干细胞及转化研究)青年项目,2017YFA0106400,骨髓间充质干细胞调控机制及其与造血干细胞的相互作用研究,2017-072021-12577万元,已结题,主持

2.国家自然科学基金委,重大研究计划(器官衰老与器官退行性变化的机制)培育项目,91749124,骨髓微环境的衰老机制研究,2018-012020-1280万元,已结题,主持

3.国家自然科学基金委,面上项目,81772389Clec11a/Osteolectin促进成骨分化的机制与临床应用研究,2018-012021-1266万元,已结题,主持  

代表论文(#Co-first author, *Co-corresponding author)

1.Zhang, Y.#, Sun, H.#, Huang, F.#, Chen, Y.#, Ding, X., Zhou, C., Wu, Y., Zhang, Q., Ma, X., Wang, J., Yue, R.*, Shen, L.*, Sun, X.*, and Ye, Z.* (2024) The chromatin remodeling factor Arid1a cooperates with Jun/Fos to promote osteoclastogenesis by epigenetically upregulating Siglec15 expression. J Bone Miner Res 39, 775-790

2.Zhang, X.#, Cao, D.#, Xu, L.#, Xu, Y.#, Gao, Z., Pan, Y., Jiang, M., Wei, Y., Wang, L., Liao, Y., Wang, Q., Yang, L., Xu, X., Gao, Y., Gao, S., Wang, J., and Yue, R. (2023) Harnessing matrix stiffness to engineer a bone marrow niche for hematopoietic stem cell rejuvenation. Cell Stem Cell 30, 378-395 e378 (Feature Article, Previewed by Cell Stem Cell)

3.Sun, Y.#, Ma, M.#, Cao, D., Zheng, A., Zhang, Y., Su, Y., Wang, J., Xu, Y., Zhou, M., Tang, Y., Liu, Y., Ma, T., Fan, A., Zhang, X., Zhu, Q., Qin, J., Mo, C., Xu, Y., Zhang, L.*, Xu, D.*, and Yue, R.* (2023) Inhibition of Fap Promotes Cardiac Repair by Stabilizing BNP. Circ Res 132, 586-600 (Feature Article)

4.Wang, J., Zhu, Q., Cao, D., Peng, Q., Zhang, X., Li, C., Zhang, C., Zhou, B. O., and Yue, R. (2023) Bone marrow-derived IGF-1 orchestrates maintenance and regeneration of the adult skeleton. Proc Natl Acad Sci U S A 120, e2203779120

5.Fan, A.#, Wu, G.#, Wang, J., Lu, L., Wang, J., Wei, H., Sun, Y., Xu, Y., Mo, C., Zhang, X., Pang, Z., Pan, Z., Wang, Y., Lu, L., Fu, G., Ma, M., Zhu, Q., Cao, D., Qin, J., Yin, F.*, and Yue, R.* (2023) Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression. Bone Res 11, 3

6.Yang, R.#, Cao, D.#, Suo, J., Zhang, L., Mo, C., Wang, M., Niu, N., Yue, R.*, and Zou, W.* (2023) Premature aging of skeletal stem/progenitor cells rather than osteoblasts causes bone loss with decreased mechanosensation. Bone Res 11, 35 (Cover Story)

7.Ren, J.#, Song, M.#, Zhang, W.#, Cai, J. P., Cao, F., Cao, Z., Chan, P., Chen, C., Chen, G., Chen, H. Z., Chen, J., Chen, X. C., Ci, W., Ding, B. S., Ding, Q., Gao, F., Gao, S., Han, J. J., He, Q. Y., Huang, K., Ju, Z., Kong, Q. P., Li, J., Li, J., Li, J., Li, X., Liu, B., Liu, F., Liu, J. P., Liu, L., Liu, Q., Liu, Q., Liu, X., Liu, Y., Luo, X., Ma, S., Ma, X., Mao, Z., Nie, J., Peng, Y., Qu, J., Ren, R., Song, W., Songyang, Z., Sun, L., Sun, Y. E., Sun, Y., Tian, M., Tian, X. L., Tian, Y., Wang, J., Wang, S., Wang, S., Wang, W., Wang, X., Wang, X., Wang, Y. J., Wang, Y., Wong, C. C. L., Xiang, A. P., Xiao, Y., Xiao, Z. X., Xie, Z., Xiong, W., Xu, D., Yang, Z., Ye, J., Yu, W., Yue, R., Zhang, C., Zhang, H., Zhang, L., Zhang, X., Zhang, Y., Zhang, Y. W., Zhang, Z., Zhao, T., Zhao, Y., Zhou, Z., Zhu, D., Zou, W., Pei, G., and Liu, G. H. (2023) The Aging Biomarker Consortium represents a new era for aging research in China. Nat Med 29, 2162-2165

8.Aging Biomarker, C., Bao, H.#, Cao, J.#, Chen, M.#, Chen, M.#, Chen, W.#, Chen, X.#, Chen, Y.#, Chen, Y.#, Chen, Y.#, Chen, Z.#, Chhetri, J. K.#, Ding, Y.#, Feng, J.#, Guo, J.#, Guo, M.#, He, C.#, Jia, Y.#, Jiang, H.#, Jing, Y.#, Li, D.#, Li, J.#, Li, J.#, Liang, Q.#, Liang, R.#, Liu, F.#, Liu, X.#, Liu, Z.#, Luo, O. J.#, Lv, J.#, Ma, J.#, Mao, K.#, Nie, J.#, Qiao, X.#, Sun, X.#, Tang, X.#, Wang, J.#, Wang, Q.#, Wang, S.#, Wang, X.#, Wang, Y.#, Wang, Y.#, Wu, R.#, Xia, K.#, Xiao, F. H.#, Xu, L.#, Xu, Y.#, Yan, H.#, Yang, L.#, Yang, R.#, Yang, Y.#, Ying, Y.#, Zhang, L.#, Zhang, W.#, Zhang, W.#, Zhang, X.#, Zhang, Z.#, Zhou, M.#, Zhou, R.#, Zhu, Q.#, Zhu, Z.#, Cao, F.*, Cao, Z.*, Chan, P.*, Chen, C.*, Chen, G.*, Chen, H. Z.*, Chen, J.*, Ci, W.*, Ding, B. S.*, Ding, Q.*, Gao, F.*, Han, J. J.*, Huang, K.*, Ju, Z.*, Kong, Q. P.*, Li, J.*, Li, J.*, Li, X.*, Liu, B.*, Liu, F.*, Liu, L.*, Liu, Q.*, Liu, Q.*, Liu, X.*, Liu, Y.*, Luo, X.*, Ma, S.*, Ma, X.*, Mao, Z.*, Nie, J.*, Peng, Y.*, Qu, J.*, Ren, J.*, Ren, R.*, Song, M.*, Songyang, Z.*, Sun, Y. E.*, Sun, Y.*, Tian, M.*, Wang, S.*, Wang, S.*, Wang, X.*, Wang, X.*, Wang, Y. J.*, Wang, Y.*, Wong, C. C. L.*, Xiang, A. P.*, Xiao, Y.*, Xie, Z.*, Xu, D.*, Ye, J.*, Yue, R.*, Zhang, C.*, Zhang, H.*, Zhang, L.*, Zhang, W.*, Zhang, Y.*, Zhang, Y. W.*, Zhang, Z.*, Zhao, T.*, Zhao, Y.*, Zhu, D.*, Zou, W.*, Pei, G.*, and Liu, G. H.* (2023) Biomarkers of aging. Sci China Life Sci 66, 893-1066

9.Zhu, Q., Ding, L., and Yue, R. (2022) Skeletal stem cells: a game changer of skeletal biology and regenerative medicine? Life Med 1, 294-306 (Cover Story)

10.Mo, C.#, Guo, J.#, Qin, J., Zhang, X., Sun, Y., Wei, H., Cao, D., Zhang, Y., Zhao, C., Xiong, Y., Zhang, Y., Sun, Y., Shen, L.*, and Yue, R.* (2022) Single-cell transcriptomics of LepR-positive skeletal cells reveals heterogeneous stress-dependent stem and progenitor pools. EMBO J 41, e108415 (Cover Story, Previewed by EMBO Journal)

11.He, J.#, Yan, J.#, Wang, J.#, Zhao, L.#, Xin, Q.#, Zeng, Y., Sun, Y., Zhang, H., Bai, Z., Li, Z., Ni, Y., Gong, Y., Li, Y., 8.He, H., Bian, Z., Lan, Y., Ma, C., Bian, L., Zhu, H.*, Liu, B.*, and Yue, R.* (2021) Dissecting human embryonic skeletal stem cell ontogeny by single-cell transcriptomic and functional analyses. Cell Res 31, 742-757 (Cover Story)

12.Jin, F., Li, J., Zhang, Y. B., Liu, X., Cai, M., Liu, M., Li, M., Ma, C., Yue, R., Zhu, Y., Lai, R., Wang, Z., Ji, X., Wei, H., Dong, J., Liu, Z., Wang, Y., Sun, Y., and Wang, X. (2021) A functional motif of long noncoding RNA Nron against osteoporosis. Nat Commun 12, 3319

13.Wei, H.#, Xu, Y.#, Wang, Y.#, Xu, L., Mo, C., Li, L., Shen, B., Sun, Y., Cheng, P., Yang, L., Pang, Y., Qin, A., Cao, Y., Morrison, S. J., and Yue, R. (2020) Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target. Cell Rep 33, e108252 (Highlighted by Nature Reviews Endocrinology, Recommended by F1000)

14.Yue, R. (2019) Advice for the Next Generation: Rui Yue. Cell Stem Cell 24, 9-11

15.Shen, B., Vardy, K., Hughes, P., Tasdogan, A., Zhao, Z., Yue, R., Crane, G. M., and Morrison, S. J. (2019) Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass. eLife 8, e42274

16.Han, X., Wang, R., Zhou, Y., Fei, L., Sun, H., Lai, S., Saadatpour, A., Zhou, Z., Chen, H., Ye, F., Huang, D., Xu, Y., Huang, W., Jiang, M., Jiang, X., Mao, J., Chen, Y., Lu, C., Xie, J., Fang, Q., Wang, Y., Yue, R., Li, T., Huang, H., Orkin, S. H., Yuan, G. C., Chen, M., and Guo, G. (2018) Mapping the Mouse Cell Atlas by Microwell-Seq. Cell 172, 1091-1107

17.Zhou, B. O., Yu, H., Yue, R., Zhao, Z., Rios, J. J., Naveiras, O., and Morrison, S. J. (2017) Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF. Nat Cell Biol 19, 891-903

18.Yue, R., Shen, B., and Morrison, S. J. (2016) Clec11a/osteolectin is an osteogenic growth factor that promotes the maintenance of the adult skeleton. eLife 5, e18782 (Previewed by eLife)

19.Yue, R., Zhou, B. O., Shimada, I. S., Zhao, Z., and Morrison, S. J. (2016) Leptin Receptor Promotes Adipogenesis and Reduces Osteogenesis by Regulating Mesenchymal Stromal Cells in Adult Bone Marrow. Cell Stem Cell 18, 782-796(Previewed by Cell Stem Cell)

20.Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G., and Morrison, S. J. (2014) Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15, 154-168

21.Li, H.#, Yue, R.#, Wei, B., Gao, G., Du, J., and Pei, G. (2014) Lysophosphatidic acid acts as a nutrient-derived developmental cue to regulate early hematopoiesis. EMBO J 33, 1383-1396

22.Yue, R.#, Li, H.#, Liu, H., Li, Y., Wei, B., Gao, G., Jin, Y., Liu, T., Wei, L., Du, J., and Pei, G. (2012) Thrombin receptor regulates hematopoiesis and endothelial-to-hematopoietic transition. Dev Cell 22, 1092-1100

23.Yue, R., Kang, J., Zhao, C., Hu, W., Tang, Y., Liu, X., and Pei, G. (2009) Beta-arrestin1 regulates zebrafish hematopoiesis through binding to YY1 and relieving polycomb group repression. Cell 139, 535-546

课题组常年招聘博士后,待遇从优。欢迎博士生硕士生本科生报考实习。

Copyright© 2011-2015 生命科学与技术学院, All rights reserved

地址:上海市四平路1239号 电话:021-65981041 传真:65981041

搜索
您想要找的